The TLC Foundation made a unique investment by supporting the 2018 International Rhabdoid Tumor Meeting in Lake Louise. Eighty-eight scientists from around the world gathered for a 2-day conference on rhabdoid tumors, with most of the focus being on Atypical Teratoid Rhabdoid Tumors (AT/RT). AT/RT is a rare pediatric brain tumor that claimed the life of Ty Louis Campbell, and that has been widely neglected by the research community until now.
There is a common phrase, “you don’t know what you don’t know” that certainly rings true in the research community. Information sharing is imperative to advancing research. This “meeting of the minds” was a tremendous accomplishment for advancing discoveries in ATRT. The collaborative group worked together to develop a classification system for ATRT’s that can be used in all clinical trials, and TLC was in attendance to see the breakthrough results presented from the anti-CD47 research we also supported.
